A liquid chromatography-mass spectrometry (LC-MS) assay was developed and validated
for the quantification of cilnidipine, a calcium channel antagonist, in human plasma. Plasma …

A rapid, sensitive and reliable high performance liquid chromatographic method coupled
with tandem mass spectrometry (HPLC–MS/MS) has been developed and validated for the …

A simple method using a one-step liquid–liquid extraction (LLE) with methyl-t-butyl ether
(MTBE) followed by high-performance liquid chromatography (HPLC) with negative-ion …

Cilnidipine is a dual blocker of L-type voltage-gated calcium channels in vascular smooth
muscle and N-type calcium channels in sympathetic nerve terminals that supply blood …

Cilnidipine [1] is a dihydropyridine (DHP) type of calcium channel antagonist. Unlike other
calcium channel antagonists, cilnidipine blocks the influx of Ca2+ ions into both vascular …

Cilnidipine is act as a dual blocker by blocking L-type of calcium channel present in vascular
smooth muscles and N-type of calcium channel present in sympathetic nerve terminal that …

Cilnidipine is one of the dihydropyridine calcium antagonists. It was created combinedly by
Fuji Viscera Pharmaceutical Company, Ajinomoto and Japan and was approved in the year …

A specific liquid chromatography–mass spectrometric (LC–MS/MS) assay was developed
and validated for the determination of lercanidipine, a dihydropyridine calcium channel …

An accurate and precise High-Performance Reversed-Phase Liquid Chromatographic and
UV spectrophotometric methods were developed and validated for the quantitative …

A rapid, simple and specific reversed-phase HPLC method has been developed for
estimation of Cilnidipine in Pharmaceutical Formulation. HPLC analysis was performed on a …